SMAD2 and colorectal carcinoma: In line with these observations, we show reduced basal levels of SMAD2 phosphorylation in Nrp2−/− CRC organoids compared to the control organoids (Figure 2c), indicating that reduced TGFβ signaling may be, at least partially, responsible for the observed EMT to MET switch.